• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Lung Cancer Initiative Names New Chief Scientific Officer and Announces 2025 Research Award Recipients

by MM360 Staff | May 7, 2025 | Uncategorized

Source: CureToday articles LCI has appointed Neal Ready, MD, PhD, as its first Chief Scientific Officer. Read More

How Quitting Smoking After a Cancer Diagnosis Can Boost Survival

by MM360 Staff | May 7, 2025 | Uncategorized

Source: CureToday articles Dr. Daniel J. Boffa discusses the link between smoking cessation and increase in survival for people who are active smokers and diagnosed with cancer. Read More

A Nurse Who Became Family After a Cancer Diagnosis

by MM360 Staff | May 7, 2025 | Uncategorized

Source: CureToday articles Eric Z. cared for my sister and mentored me with compassion, wisdom and unwavering presence — shaping my path in nursing and life. Read More

Cemsidomide Generates Results at Multiple Doses in Multiple Myeloma

by MM360 Staff | May 7, 2025 | Uncategorized

Source: CureToday articles Treatment with cemsidomide resulted in notable responses at multiple dose levels for patients with multiple myeloma Read More

Enhertu Regimen Improves Responses in High-Risk HER2+ Breast Cancer

by MM360 Staff | May 7, 2025 | Uncategorized

Source: CureToday articles Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk HER2-positive early-stage breast cancer. Read More

Breast Cancer Survivor Reflects on 30 Years, Urges Informed Decisions

by MM360 Staff | May 7, 2025 | Uncategorized

Source: CureToday articles After 30 years with breast cancer, I urge others to pause, reflect and choose care based on long-term wellbeing, not fear or pressure. Read More
« Older Entries
Next Entries »

Recent Content

  • (no title)
  • New targeted cancer therapy IDE034 heading to Phase 1 clinical trial
  • (no title)
  • Tecvayli-Darzalex Faspro combo up for approval in 2 nations for treating RRMM
  • In vivo CAR-T exhibits activity in advanced multiple myeloma
  • FDA backs faster development of new therapy for hard-to-treat AML
  • The efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials
  • Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy
  • Correction: Chen et al. The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis. Diagnostics 2024, 14, 1030
  • Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT